3 Bottles of LIV Capsules


Balancing IMmunity (BIM) in relation to HIV treatment
Benefits of LIV capsules:
  • Scientifically proven to increase CD4 count
  • Proven to increase Th1, Th9, and Th17 which enhance the activity of natural killer cells and Cytotoxic T cells, thus strengthening the immune system to improve quality of life
  • Reduce side effects caused by antiretroviral drugs
  • 100% all natural plant-based ingredients
  • Take 2-3 capsules (3 times a day); 1 hour before meal or 1 hour before bedtime.

60 Capsules per bottle: 180 capsules in total


Worldwide Shipment Flat Rate: 400 Thai Baht per 3 bottles.

SKU: 3-bottles-liv


The LIV capsule is a natural food supplement formulated from GM-1 Polysaccharide Synergistic Complex of mangosteen extract powder and Centella asiatica juice powder, and enhanced with SG-Protein Synergistic Complex of black sesame extract, guava fruit juice powder and isolated soy protein.

The type of CD4 cells that HIV destroys most are Th17 cells which are an essential part of the immune system.

Once a person is affected with HIV, the virus penetrates into their white blood cells known as CD4 which are responsible in boosting the immune system. The virus then destroys those CD4 cells and moves to destroy other CD4 cells. HIV hides in the white blood cells making it difficult to detect and kill.

As the immune system of HIV-affected persons weaken, they become prone to other opportunistic infections caused by bacteria, fungi and other viruses. Increasing Th17 cells can help control the spread of HIV. A study revealed that if the body has adequate Th17 cells, these Th17 cells will act like a vaccine for the body against HIV.

Research conducted on 27 HIV-affected volunteers by Prof. Dr. Watchara Kasinrerk (APCO Chair Professor) and Nopporn Pattanapornpun, MD (Director Of Mae-On Hospital in Chiang Mai), showed that the CD4 cell counts in HIV patients increased significantly after taking four LIV capsules daily for 3-6 months. APCO has since donated a life-time supply of LIV capsules to the 27 HIV-affected volunteers who took part in this research study.